Satellos Bioscience MSLE
NASDAQ MSLE
$6.70 -0.30 (-4.29%)
At close: Oct 21, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Total Current Liabilities (2023 - 2026)

Updated

Satellos Bioscience (MSLE) reported Total Current Liabilities of $5.86 million for the quarter ended Jun 30, 2026, up 28.4% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Total Current Liabilities (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Satellos Bioscience posted Total Current Liabilities of $4.11 million, up 14.6% from the prior year.

  • By year, Total Current Liabilities came in at $3.58 million in the year ended Dec 31, 2024 (+31.1%) and $2.73 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Satellos Bioscience 98.81 Mn -109.33 Mn - 5.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.86 Mn
Mar 31, 2026 4.56 Mn
Dec 31, 2025 4.11 Mn
Dec 31, 2024 3.59 Mn
Dec 31, 2023 2.74 Mn
API Access

Satellos Bioscience Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=MSLE&period=max&api_key=YOUR_API_KEY